Clinical Trial Update: Demonstration of Bioequivalence of Empagliflozin and Metformin Given in One Tablet Compared to the Intake of Single Tablets [Phase 1]

View source ↗

Summary

A Phase 1 trial in healthy volunteers demonstrated bioequivalence of a fixed-dose combination tablet containing empagliflozin and metformin compared with taking…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Glucophage (metformin)
• Jardiance (empagliflozin)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Healthy | Phase 1 | Status: COMPLETED | Results posted: 2015-08-31